Celltrion Pharm

068760.KQ

39.56 USD

-0.21

-0.53%

Overview

Last close

39.56 usd

Market cap

1.64B usd

52 week high

98.52 usd

52 week low

38.29 usd

Target price

96.75 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.4512

Price/Book Value

5.9324

Enterprise Value

1.74B usd

EV/Revenue

5.5866

EV/EBITDA

26.9629

Key financials

Revenue TTM

195.45M usd

Gross Profit TTM

51.89M usd

EBITDA TTM

30.45M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

639.79B usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.